BioStem Technologies (OTCMKTS:BSEM) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

BioStem Technologies (OTCMKTS:BSEM) released its earnings results on Tuesday. The company reported 0.32 earnings per share for the quarter, beating the consensus estimate of 0.31 by 0.01, Zacks reports. The firm had revenue of 82.56 million during the quarter, compared to analyst estimates of 78.22 million.

BioStem Technologies Stock Performance

BSEM stock opened at 23.36 on Thursday. BioStem Technologies has a fifty-two week low of 2.34 and a fifty-two week high of 28.26. The company’s 50 day moving average price is 13.03 and its 200 day moving average price is 10.55. The firm has a market capitalization of $388.16 million, a price-to-earnings ratio of 36.74 and a beta of -0.36.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.